LU72273A1 - - Google Patents

Info

Publication number
LU72273A1
LU72273A1 LU72273A LU72273A LU72273A1 LU 72273 A1 LU72273 A1 LU 72273A1 LU 72273 A LU72273 A LU 72273A LU 72273 A LU72273 A LU 72273A LU 72273 A1 LU72273 A1 LU 72273A1
Authority
LU
Luxembourg
Application number
LU72273A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU72273A1 publication Critical patent/LU72273A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/85Reproductive organs or embryos
    • Y10S530/851Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
LU72273A 1974-04-12 1975-04-11 LU72273A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7413019A FR2267115B1 (es) 1974-04-12 1974-04-12

Publications (1)

Publication Number Publication Date
LU72273A1 true LU72273A1 (es) 1975-08-20

Family

ID=9137624

Family Applications (1)

Application Number Title Priority Date Filing Date
LU72273A LU72273A1 (es) 1974-04-12 1975-04-11

Country Status (15)

Country Link
US (1) US4137222A (es)
JP (1) JPS5529053B2 (es)
AR (1) AR205926A1 (es)
BE (1) BE827852A (es)
BR (1) BR7502230A (es)
CA (1) CA1050885A (es)
DE (1) DE2515666C3 (es)
DK (1) DK139659B (es)
ES (1) ES436525A1 (es)
FR (1) FR2267115B1 (es)
GB (1) GB1469908A (es)
LU (1) LU72273A1 (es)
NL (1) NL7504365A (es)
NO (1) NO143478C (es)
SE (1) SE403705B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
DE2837168A1 (de) * 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
FR2556219B1 (fr) * 1983-12-07 1987-06-26 Merieux Inst Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines
IL149687A0 (en) * 2002-05-15 2002-11-10 Alexander Condrea Cervical dilator
US20090123560A1 (en) * 2005-09-16 2009-05-14 Kenji Yoshida Hematopoietic Stem Cell Proliferation Inducing Agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK79841C (da) * 1952-08-04 1955-09-12 Behringwerke Ag Fremgangsmåde til fremstilling af stabile γ-globulinpræparater.
US2922745A (en) * 1958-01-10 1960-01-26 Ortho Pharma Corp Purification of profibrinolysin
NL286954A (es) * 1962-01-03
US3382227A (en) * 1967-01-30 1968-05-07 Pentex Inc Blood protein fractionation employing 2-ethoxy-6, 9-diamino-acridine-lactate
BE789523A (fr) * 1971-09-29 1973-03-29 Behringwerke Ag B1-glycoproteine specifique de la grossesse et son procede d'isolement
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
US3808124A (en) * 1972-04-14 1974-04-30 American Cyanamid Co Purification of human plasminogen
US3943245A (en) * 1974-02-14 1976-03-09 Armour Pharmaceutical Company Purification of plasminogen

Also Published As

Publication number Publication date
NL7504365A (nl) 1975-10-14
NO751295L (es) 1975-10-14
DK139659B (da) 1979-03-26
DK158075A (es) 1975-10-13
ES436525A1 (es) 1977-01-01
JPS5529053B2 (es) 1980-07-31
DE2515666C3 (de) 1980-06-26
NO143478B (no) 1980-11-17
SE403705B (sv) 1978-09-04
NO143478C (no) 1981-02-25
FR2267115B1 (es) 1977-11-10
BE827852A (fr) 1975-10-13
SE7504196L (sv) 1975-10-13
FR2267115A1 (es) 1975-11-07
GB1469908A (en) 1977-04-06
CA1050885A (fr) 1979-03-20
DE2515666A1 (de) 1975-10-23
JPS50145517A (es) 1975-11-21
BR7502230A (pt) 1976-02-10
US4137222A (en) 1979-01-30
DK139659C (es) 1979-09-17
DE2515666B2 (de) 1979-10-18
AR205926A1 (es) 1976-06-15

Similar Documents

Publication Publication Date Title
FR2256819A1 (es)
FR2269456A1 (es)
FR2267115B1 (es)
DK68075A (es)
FR2287980B3 (es)
FR2260921B1 (es)
JPS50103845U (es)
CS176504B1 (es)
FI751440A (es)
JPS50102096A (es)
HU168369B (es)
CH568134A5 (es)
CH1163975A4 (es)
AU480471A (es)
CH581044A5 (es)
CH17274A4 (es)
CH569666A5 (es)
CH569220A5 (es)
CH568539A5 (es)
CH562462A5 (es)
CH566915A5 (es)
CH566410A5 (es)
CH564833A5 (es)
CH563933A5 (es)
CH562521A5 (es)